Emily Jean Aller

2PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 28, 2025
Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target.

Emily J Aller, Hareesh B Nair, Ratna K Vadlamudi

|Dec 23, 2023
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.

Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam

Pageof 1